Sensona provides an explicit solution to sophisticated PCR-based diagnostic instrumentation, delivering a portable, ultrafast system that enables the completion of clinical sample analysis within minutes. Our objective is to enhance the Global Health System, combat the escalating antibiotic resistance crisis, and preempt or shorten outbreaks by introducing an innovative diagnostic platform that provides cost-effective tests at the point of care. Sensona has secured patents for its technology in 32 countries across North America, the European Union, and the Asia-Pacific region.